Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
PROF
PROF
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PROF News
Profound Medical Receives 2025/2026 Mount Logan Award for Innovation
4d ago
Newsfilter
Mount Sinai Performs First AI-Powered Prostate Treatment, Enhancing Patient Quality of Life
Jan 15 2026
Globenewswire
Profound Medical Completes $6.45 Million Private Placement to Expand Operations
Dec 30 2025
Globenewswire
Profound Medical Corp. Raises $6.45 Million in Expanded Private Placement
Dec 26 2025
Newsfilter
Profound Medical Raises $6.45 Million in Expanded Private Placement for Business Growth
Dec 24 2025
Globenewswire
Profound Medical Corp. Raises $40 Million Through Share Offering at $7 Each
Dec 19 2025
Newsfilter
Profound Medical Receives RSNA Cum Laude Award, TULSA Procedure Significantly Reduces Patient Recovery Time
Dec 04 2025
Globenewswire
Profound Unveils AI-Driven BPH Module and Showcases New TULSA-PRO Clinical Findings at RSNA and SUO 2025
Dec 01 2025
NASDAQ.COM
Profound Medical Launches TULSA-AI Module, Targeting 600,000 Annual Patients
Nov 28 2025
Newsfilter
Profound Medical (PROF) Receives Upgrade to Buy: Implications for the Stock
Nov 19 2025
NASDAQ.COM
Profound Medical Corp. Sees Decrease in Q3 Profit
Nov 13 2025
NASDAQ.COM
Profound Medical Partners with Getz Healthcare to Distribute TULSA-PRO® in Australia and New Zealand
Nov 12 2025
Newsfilter
Profound Medical Reacquires Exclusive Distribution Rights for TULSA-PRO® in Canada from Knight
Nov 10 2025
Newsfilter
Profound Medical Reports Significant Q3 Preliminary Revenue Growth, Yet Falls Short of Expectations
Oct 07 2025
NASDAQ.COM
Profound Medical Reports Record Preliminary Unaudited Revenue for Q3 2025
Oct 07 2025
Newsfilter
Profound Medical Gains Momentum with Launch of TULSA Procedure at Dallas Medical Center
Sep 23 2025
SeekingAlpha
Show More News
